September 1st 2025
The FDA has cleared Eisai and Biogen’s Leqembi Iqlik, the first at-home subcutaneous autoinjector for maintenance therapy in patients with early Alzheimer disease.
Burden of Atrial Fibrillation in Patients with Ischemic Stroke is Substantial According to New Study
February 11th 2022Atrial fibrillation-related ischemic stroke may be a factor in hospital deaths among over 50% of older adults, suggests new findings presented at the International Stroke Conference.
Metabolically Healthy Obesity May Increase Risk of Heart Failure, but Not Heart Attack or Stroke
October 5th 2021EASD 2021: Patients with metabolically healthy obesity are nearly 33% more likely to develop heart failure and atrial fibrillation than healthy persons of normal weight, suggests new analysis.